한글목차

염증성 장질환용 AI시장은 2024-2029년에 3억 1,210만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 33.3%를 보일 것으로 예측됩니다.

염증성 장질환용 AI 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 진단 정확도 향상과 개인화된 치료 경로의 필요성, 헬스케어 분야의 AI 기능의 급속한 발전과 빅데이터의 확산, 혁신을 촉진하는 투자와 전략적 산업 협업의 급증에 의해 주도되고 있습니다.

본 조사는 업계 주요 참여자들의 의견을 포함하여 1차 정보와 2차 정보를 객관적으로 조합하여 실시되었습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

본 조사는 향후 몇 년 동안 염증성 장 질환에서 AI 시장의 성장을 가속하는 주요 이유 중 하나로 진단의 확장에서 예측 및 예후 지능으로의 진화를 꼽았습니다. 또한, 신약 발견과 치료법 개발의 엔진으로서 AI의 부상, 기업 차원의 통합과 입증 가능한 워크플로우 효율성으로의 전략적 전환은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 질환 유형별

• 시장 부문
• 비교 : 질환 유형별
• 궤양성 대장염 : 시장 규모와 예측(2024-2029년)
• 크론병 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 질환 유형별

제7장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 진단 지원 : 시장 규모와 예측(2024-2029년)
• 치료 최적화 : 시장 규모와 예측(2024-2029년)
• 질병 모니터링 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 용도별

제8장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측(2024-2029년)
• 전문 클리닉 : 시장 규모와 예측(2024-2029년)
• 진단 실험실 : 시장 규모와 예측(2024-2029년)
• 학술연구기관 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제9장 고객 상황

• 고객 상황 개요

제10장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아태평양 : 시장 규모와 예측(2024-2029년)
• 남미 : 시장 규모와 예측(2024-2029년)
• 중동 및 아프리카 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 브라질 : 시장 규모와 예측(2024-2029년)
• 호주 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제11장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제12장 경쟁 구도

• 개요
• 경쟁 구도
• 파괴적 혁신 상황
• 업계 리스크

제13장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Bayer AG
• BenevolentAI
• Dova Health Intelligence Inc.
• F. Hoffmann La Roche Ltd.
• Insilico Medicine
• International Business Machines Corp.
• Olympus Corp.
• Owkin Inc.
• PathAI Inc.
• Pfizer Inc.
• Siemens Healthineers AG
• SingHealth Group.
• Takeda Pharmaceutical Co. Ltd.
• Tempus Labs Inc.

제14장 부록

영문목차

The global AI in inflammatory bowel disease market is forecasted to grow by USD 312.1 mn during 2024-2029, accelerating at a CAGR of 33.3% during the forecast period. The report on the global AI in inflammatory bowel disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative for enhanced diagnostic accuracy and personalized treatment pathways, rapid advancements in AI capabilities and proliferation of big data in healthcare, and surging investment and strategic industry collaborations fueling innovation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global AI in inflammatory bowel disease market is segmented as below:

By Disease Type

• Ulcerative colitis
• Crohns disease

By Application

• Diagnosis assistance
• Treatment optimization
• Disease monitoring

By End-user

• Hospitals
• Specialty clinics
• Diagnostic laboratories
• Academic and research institutes

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the evolution from diagnostic augmentation to predictive and prognostic intelligence as one of the prime reasons driving the global AI in inflammatory bowel disease market growth during the next few years. Also, ascendance of AI as engine for novel drug discovery and therapeutic development and strategic shift towards enterprise-level integration and demonstrable workflow efficiency will lead to sizable demand in the market.

The report on the global AI in inflammatory bowel disease market covers the following areas:

• Global AI In Inflammatory Bowel Disease Market sizing
• Global AI In Inflammatory Bowel Disease Market forecast
• Global AI In Inflammatory Bowel Disease Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global AI in inflammatory bowel disease market vendors that include AbbVie Inc., Bayer AG, BenevolentAI, Dova Health Intelligence Inc., F. Hoffmann La Roche Ltd., Insilico Medicine, International Business Machines Corp., Olympus Corp., Owkin Inc., PathAI Inc., Pfizer Inc., Siemens Healthineers AG, SingHealth Group., Takeda Pharmaceutical Co. Ltd., and Tempus Labs Inc.. Also, the global AI in inflammatory bowel disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 5.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

6 Market Segmentation by Disease Type

• 6.1 Market segments
  • Chart on Disease Type - Market share 2024-2029 (%)
  • Data Table on Disease Type - Market share 2024-2029 (%)
• 6.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 6.3 Ulcerative colitis - Market size and forecast 2024-2029
  • Chart on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
  • Data Table on Ulcerative colitis - Market size and forecast 2024-2029 ($ million)
  • Chart on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
  • Data Table on Ulcerative colitis - Year-over-year growth 2024-2029 (%)
• 6.4 Crohns disease - Market size and forecast 2024-2029
  • Chart on Crohns disease - Market size and forecast 2024-2029 ($ million)
  • Data Table on Crohns disease - Market size and forecast 2024-2029 ($ million)
  • Chart on Crohns disease - Year-over-year growth 2024-2029 (%)
  • Data Table on Crohns disease - Year-over-year growth 2024-2029 (%)
• 6.5 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 7.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 7.3 Diagnosis assistance - Market size and forecast 2024-2029
  • Chart on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
  • Data Table on Diagnosis assistance - Market size and forecast 2024-2029 ($ million)
  • Chart on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
  • Data Table on Diagnosis assistance - Year-over-year growth 2024-2029 (%)
• 7.4 Treatment optimization - Market size and forecast 2024-2029
  • Chart on Treatment optimization - Market size and forecast 2024-2029 ($ million)
  • Data Table on Treatment optimization - Market size and forecast 2024-2029 ($ million)
  • Chart on Treatment optimization - Year-over-year growth 2024-2029 (%)
  • Data Table on Treatment optimization - Year-over-year growth 2024-2029 (%)
• 7.5 Disease monitoring - Market size and forecast 2024-2029
  • Chart on Disease monitoring - Market size and forecast 2024-2029 ($ million)
  • Data Table on Disease monitoring - Market size and forecast 2024-2029 ($ million)
  • Chart on Disease monitoring - Year-over-year growth 2024-2029 (%)
  • Data Table on Disease monitoring - Year-over-year growth 2024-2029 (%)
• 7.6 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

8 Market Segmentation by End-user

• 8.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 8.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2024-2029
  • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
• 8.4 Specialty clinics - Market size and forecast 2024-2029
  • Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
• 8.5 Diagnostic laboratories - Market size and forecast 2024-2029
  • Chart on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
  • Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
  • Chart on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
  • Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
• 8.6 Academic and research institutes - Market size and forecast 2024-2029
  • Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
  • Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
  • Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
  • Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
• 8.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 10.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 10.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 10.5 APAC - Market size and forecast 2024-2029
  • Chart on APAC - Market size and forecast 2024-2029 ($ million)
  • Data Table on APAC - Market size and forecast 2024-2029 ($ million)
  • Chart on APAC - Year-over-year growth 2024-2029 (%)
  • Data Table on APAC - Year-over-year growth 2024-2029 (%)
• 10.6 South America - Market size and forecast 2024-2029
  • Chart on South America - Market size and forecast 2024-2029 ($ million)
  • Data Table on South America - Market size and forecast 2024-2029 ($ million)
  • Chart on South America - Year-over-year growth 2024-2029 (%)
  • Data Table on South America - Year-over-year growth 2024-2029 (%)
• 10.7 Middle East and Africa - Market size and forecast 2024-2029
  • Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
• 10.8 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 10.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 10.10 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 10.11 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 10.12 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 10.13 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 10.14 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 10.15 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 10.16 Brazil - Market size and forecast 2024-2029
  • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• 10.17 Australia - Market size and forecast 2024-2029
  • Chart on Australia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Australia - Market size and forecast 2024-2029 ($ million)
  • Chart on Australia - Year-over-year growth 2024-2029 (%)
  • Data Table on Australia - Year-over-year growth 2024-2029 (%)
• 10.18 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers
• 11.2 Market challenges
• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview
• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 12.3 Landscape disruption
  • Overview on factors of disruption
• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered
• 13.2 Company ranking index
  • Company ranking index
• 13.3 Market positioning of companies
  • Matrix on companies position and classification
• 13.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 13.5 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 13.6 BenevolentAI
  • BenevolentAI - Overview
  • BenevolentAI - Product / Service
  • BenevolentAI - Key offerings
  • SWOT
• 13.7 Dova Health Intelligence Inc.
  • Dova Health Intelligence Inc. - Overview
  • Dova Health Intelligence Inc. - Product / Service
  • Dova Health Intelligence Inc. - Key offerings
  • SWOT
• 13.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 13.9 Insilico Medicine
  • Insilico Medicine - Overview
  • Insilico Medicine - Product / Service
  • Insilico Medicine - Key offerings
  • SWOT
• 13.10 International Business Machines Corp.
  • International Business Machines Corp. - Overview
  • International Business Machines Corp. - Business segments
  • International Business Machines Corp. - Key news
  • International Business Machines Corp. - Key offerings
  • International Business Machines Corp. - Segment focus
  • SWOT
• 13.11 Olympus Corp.
  • Olympus Corp. - Overview
  • Olympus Corp. - Business segments
  • Olympus Corp. - Key news
  • Olympus Corp. - Key offerings
  • Olympus Corp. - Segment focus
  • SWOT
• 13.12 Owkin Inc.
  • Owkin Inc. - Overview
  • Owkin Inc. - Product / Service
  • Owkin Inc. - Key offerings
  • SWOT
• 13.13 PathAI Inc.
  • PathAI Inc. - Overview
  • PathAI Inc. - Product / Service
  • PathAI Inc. - Key offerings
  • SWOT
• 13.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 13.15 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key news
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 13.16 SingHealth Group.
  • SingHealth Group. - Overview
  • SingHealth Group. - Product / Service
  • SingHealth Group. - Key offerings
  • SWOT
• 13.17 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 13.18 Tempus Labs Inc.
  • Tempus Labs Inc. - Overview
  • Tempus Labs Inc. - Product / Service
  • Tempus Labs Inc. - Key offerings
  • SWOT

14 Appendix

• 14.1 Scope of the report
• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 14.4 Research methodology
  • Research methodology
• 14.5 Data procurement
  • Information sources
• 14.6 Data validation
  • Data validation
• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 14.8 Data synthesis
  • Data synthesis
• 14.9 360 degree market analysis
  • 360 degree market analysis
• 14.10 List of abbreviations
  • List of abbreviations